Abstract
Background
Systemic anticoagulation after pediatric liver transplantation (pLT) is believed to reduce the incidence of vascular thrombosis, but it may also cause an increase in hemorrhagic complications.
Procedure
A 5‐year retrospective review of pLT done at our institution was performed (2014–2018). The occurrence of early hemorrhagic and thrombotic complications was compared when using low‐dose or high‐dose anticoagulation after transplant (p < .05 considered significant).
Results
Sixty‐nine patients received 73 transplants during the study period. Median age at transplant was 2.3 years (40 days to 18.5 years). Low‐dose anticoagulation was utilized in 71% cases. Additionally, six patients were converted from low‐dose to high‐dose anticoagulation because of a thrombotic event or concerns for suboptimal vascular inflow. Postoperative anticoagulation was discontinued in 18 occurrences due to bleeding (low dose 19%, high dose 47% vs. low dose to high dose 17%, p = .085). Surgical take back for bleeding occurred in 17 occasions (low dose 13.5%, high dose 53% vs. low dose to high dose 33%, p = .005). The overall incidence of hepatic artery thrombosis (HAT) and portal vein thrombosis were each 5.5%, respectively. While patient survival was not statistically different between groups, graft survival was significantly lower in the high‐dose group (low dose 93%, high dose 73% vs. low dose to high dose 100%, p = .046). However, graft losses from HAT were similar between groups (low dose 2%, high dose 7% vs. low dose to high dose 0%, p = .56).
Conclusion
The use of a standardized risk‐adjusted anticoagulation protocol after pLT is associated with a low occurrence of thrombotic and hemorrhagic complications. High‐dose anticoagulation leads to more bleeding, but those risks outweigh the risks of possible graft loss.
